Clinical evidence for healthspan.
Visit geroevidence.com ↗Longevity medicine moves fast. New trials, meta-analyses, and case series publish weekly across dozens of journals. Physicians prescribing off-label interventions need current evidence — but monitoring PubMed manually across a dozen compounds is not a workflow.
Geroevidence aggregates, filters, and surfaces longevity medicine research daily — rapamycin, metformin, GLP-1 agonists, senolytics, NAD+ precursors, and more. Every alert is human-reviewed before it reaches subscribers, so the signal-to-noise ratio stays high.
Visit geroevidence.com to start a free trial or learn more about pricing.
Go to Geroevidence ↗